after the treatment with anti-moloney sera the number of mulv-releasing cells decreased 10-fold and the leukemogenic potential in vivo decreased 100-fold as compared to leukemic spleen cells pretreated with nonimmune mouse and rat sera ( plus complement ) .
C0229671
sera
C0009498
complement